Search results
Obesity, diabetes drugs’ PLI scheme in India soon: Report
The Economic Times· 6 days agoThe government is set to introduce a production-linked incentive (PLI) programme in 2026 for...
Moneycontrol Pro Panorama | The sound of financial stability
CNBC Awaaz· 6 days agoEver tried to hear the sound of raindrops during a storm? Financial stability is like the sound of...
Buy UltraTech Cement; target of Rs 13,000: Sharekhan
CNBC Awaaz· 3 days agoSharekhan is bullish on UltraTech Cement has recommended buy rating on the stock with a target price of Rs 13,000 in its research report dated June 28,...
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 6 days agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
Stock market update: Nifty Pharma index advances 0.14%
The Economic Times· 3 days agoThe Nifty Pharma index closed 0.14 per cent up at 19758.25.
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 3 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
How resilient is the global biopharma industry?
Pharmaceutical Technology· 3 days agoThe Global Biopharma Resilience Index reveals how the industry is performing across five key pillars to answer the all-important question: how can...
Stock market update: Nifty Pharma index advances 0.11% in a weak market
The Economic Times· 3 days agoThe Nifty Pharma index was trading 0.11 per cent up at 19780.3.
Taking Stock: Market bounces back; Nifty at 24,150, Sensex up 443 points
CNBC Awaaz· 3 days agoTop Nifty gainers included Tech Mahindra, Wipro, Bajaj Finance, UltraTech Cement and Grasim...
Accumulate Bharti Airtel; target of Rs 1,620: Prabhudas Lilladher
CNBC Awaaz· 4 days agoPrabhudas Lilladher recommended accumulate rating on Bharti Airtel with a target price of Rs 1,620...